For research use only
| Cat No. | ABC-SC223Y |
| Product Type | IPSC-derived |
| Cell Type | Cortical GABAergic Neuron |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Induced pluripotent stem cell |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human iPSC-derived cortical GABAergic neuron from a sporadic Alzheimer's disease patient, ready for neurodegeneration studies and assay work.
HighQC™ Human iPSC-Derived Cortical GABAergic Neuron (Alzheimer’s Disease Patient, Sporadic) are an advanced model for studying the mechanisms of neurodegeneration in Alzheimer’s disease, particularly focusing on GABAergic neurons in the cortex. These neurons are derived from human induced pluripotent stem cells (iPSCs) of Alzheimer’s disease patients and represent a sporadic form of the disease, which is characterized by the sporadic accumulation of amyloid plaques and tau tangles. These iPSC-derived GABAergic neurons exhibit typical cortical neuron morphology and functionality, with the ability to produce GABA (gamma-aminobutyric acid), an essential inhibitory neurotransmitter. These neurons are valuable for investigating synaptic dysfunction, neurotransmitter imbalances, and the role of GABAergic signaling in the progression of Alzheimer’s disease. As a human-relevant model, they allow researchers to explore disease mechanisms that are not easily replicated in traditional animal models. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria
| Species | Human |
| Cat.No | ABC-SC223Y |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Cortical GABAergic Neuron |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Induced pluripotent stem cell |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | IPSC-derived |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
HighQC™ Human iPSC-Derived Cortical GABAergic Neuron offer a relevant model for investigating the role of GABAergic dysfunction in Alzheimer’s disease. They are critical for studying synaptic impairment, neuroinflammation, and neurodegeneration, particularly in the context of sporadic Alzheimer’s where the underlying molecular mechanisms are not fully understood. Researchers can use these neurons to explore neurotransmitter imbalances, test drug candidates for cognitive enhancement, and examine potential therapies for restoring GABAergic signaling. Additionally, these neurons can serve as an effective model for in vitro drug screening and toxicity testing for Alzheimer’s disease therapies, offering insights into neuronal health and neuroprotective strategies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).